A cross-study transcriptional analysis of Parkinson's disease.
The study of Parkinson's disease (PD), like other complex neurodegenerative disorders, is limited by access to brain tissue from patients with a confirmed diagnosis. Alternatively the study of peripheral tissues may offer some insight into the molecular basis of disease susceptibility and progr...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2009
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/375fd398b1ec4d06a8fa69cc921bba73 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:375fd398b1ec4d06a8fa69cc921bba73 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:375fd398b1ec4d06a8fa69cc921bba732021-11-25T06:16:33ZA cross-study transcriptional analysis of Parkinson's disease.1932-620310.1371/journal.pone.0004955https://doaj.org/article/375fd398b1ec4d06a8fa69cc921bba732009-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19305504/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203The study of Parkinson's disease (PD), like other complex neurodegenerative disorders, is limited by access to brain tissue from patients with a confirmed diagnosis. Alternatively the study of peripheral tissues may offer some insight into the molecular basis of disease susceptibility and progression, but this approach still relies on brain tissue to benchmark relevant molecular changes against. Several studies have reported whole-genome expression profiling in post-mortem brain but reported concordance between these analyses is lacking. Here we apply a standardised pathway analysis to seven independent case-control studies, and demonstrate increased concordance between data sets. Moreover data convergence increased when the analysis was limited to the five substantia nigra (SN) data sets; this highlighted the down regulation of dopamine receptor signaling and insulin-like growth factor 1 (IGF1) signaling pathways. We also show that case-control comparisons of affected post mortem brain tissue are more likely to reflect terminal cytoarchitectural differences rather than primary pathogenic mechanisms. The implementation of a correction factor for dopaminergic neuronal loss predictably resulted in the loss of significance of the dopamine signaling pathway while axon guidance pathways increased in significance. Interestingly the IGF1 signaling pathway was also over-represented when data from non-SN areas, unaffected or only terminally affected in PD, were considered. Our findings suggest that there is greater concordance in PD whole-genome expression profiling when standardised pathway membership rather than ranked gene list is used for comparison.Greg T SutherlandNicholas A MatigianAlistair M ChalkMatthew J AndersonPeter A SilburnAlan Mackay-SimChristine A WellsGeorge D MellickPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 4, Iss 3, p e4955 (2009) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Greg T Sutherland Nicholas A Matigian Alistair M Chalk Matthew J Anderson Peter A Silburn Alan Mackay-Sim Christine A Wells George D Mellick A cross-study transcriptional analysis of Parkinson's disease. |
| description |
The study of Parkinson's disease (PD), like other complex neurodegenerative disorders, is limited by access to brain tissue from patients with a confirmed diagnosis. Alternatively the study of peripheral tissues may offer some insight into the molecular basis of disease susceptibility and progression, but this approach still relies on brain tissue to benchmark relevant molecular changes against. Several studies have reported whole-genome expression profiling in post-mortem brain but reported concordance between these analyses is lacking. Here we apply a standardised pathway analysis to seven independent case-control studies, and demonstrate increased concordance between data sets. Moreover data convergence increased when the analysis was limited to the five substantia nigra (SN) data sets; this highlighted the down regulation of dopamine receptor signaling and insulin-like growth factor 1 (IGF1) signaling pathways. We also show that case-control comparisons of affected post mortem brain tissue are more likely to reflect terminal cytoarchitectural differences rather than primary pathogenic mechanisms. The implementation of a correction factor for dopaminergic neuronal loss predictably resulted in the loss of significance of the dopamine signaling pathway while axon guidance pathways increased in significance. Interestingly the IGF1 signaling pathway was also over-represented when data from non-SN areas, unaffected or only terminally affected in PD, were considered. Our findings suggest that there is greater concordance in PD whole-genome expression profiling when standardised pathway membership rather than ranked gene list is used for comparison. |
| format |
article |
| author |
Greg T Sutherland Nicholas A Matigian Alistair M Chalk Matthew J Anderson Peter A Silburn Alan Mackay-Sim Christine A Wells George D Mellick |
| author_facet |
Greg T Sutherland Nicholas A Matigian Alistair M Chalk Matthew J Anderson Peter A Silburn Alan Mackay-Sim Christine A Wells George D Mellick |
| author_sort |
Greg T Sutherland |
| title |
A cross-study transcriptional analysis of Parkinson's disease. |
| title_short |
A cross-study transcriptional analysis of Parkinson's disease. |
| title_full |
A cross-study transcriptional analysis of Parkinson's disease. |
| title_fullStr |
A cross-study transcriptional analysis of Parkinson's disease. |
| title_full_unstemmed |
A cross-study transcriptional analysis of Parkinson's disease. |
| title_sort |
cross-study transcriptional analysis of parkinson's disease. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2009 |
| url |
https://doaj.org/article/375fd398b1ec4d06a8fa69cc921bba73 |
| work_keys_str_mv |
AT gregtsutherland acrossstudytranscriptionalanalysisofparkinsonsdisease AT nicholasamatigian acrossstudytranscriptionalanalysisofparkinsonsdisease AT alistairmchalk acrossstudytranscriptionalanalysisofparkinsonsdisease AT matthewjanderson acrossstudytranscriptionalanalysisofparkinsonsdisease AT peterasilburn acrossstudytranscriptionalanalysisofparkinsonsdisease AT alanmackaysim acrossstudytranscriptionalanalysisofparkinsonsdisease AT christineawells acrossstudytranscriptionalanalysisofparkinsonsdisease AT georgedmellick acrossstudytranscriptionalanalysisofparkinsonsdisease AT gregtsutherland crossstudytranscriptionalanalysisofparkinsonsdisease AT nicholasamatigian crossstudytranscriptionalanalysisofparkinsonsdisease AT alistairmchalk crossstudytranscriptionalanalysisofparkinsonsdisease AT matthewjanderson crossstudytranscriptionalanalysisofparkinsonsdisease AT peterasilburn crossstudytranscriptionalanalysisofparkinsonsdisease AT alanmackaysim crossstudytranscriptionalanalysisofparkinsonsdisease AT christineawells crossstudytranscriptionalanalysisofparkinsonsdisease AT georgedmellick crossstudytranscriptionalanalysisofparkinsonsdisease |
| _version_ |
1718413975257874432 |